BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7619871)

  • 1. Preference for sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm.
    Käll K; Nilsonne A
    AIDS Care; 1995; 7(2):171-88. PubMed ID: 7619871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Little HIV risk behavior in drug users during detention in Dutch penitentiaries].
    van Haastrecht HJ; Bax JS; van den Hoek JA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(9):429-33. PubMed ID: 9173303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amphetamine on sexual behavior of male i.v. drug users in Stockholm--a pilot study.
    Käll KI
    AIDS Educ Prev; 1992; 4(1):6-17. PubMed ID: 1543645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Constant annual incidence of HIV infection among intravenous drug addicts].
    Käll K; Olin R
    Lakartidningen; 1992 Sep; 89(36):2837-40. PubMed ID: 1405878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injecting and sexual risk-taking behaviour among regular amphetamine users.
    Darke S; Ross J; Cohen J; Hando J; Hall W
    AIDS Care; 1995; 7(1):19-26. PubMed ID: 7748906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.
    Käll KI; Olin RG
    AIDS; 1990 Feb; 4(2):153-7. PubMed ID: 2328098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia.
    Abel-Ollo K; Rahu M; Rajaleid K; Talu A; Ruutel K; Platt L; Bobrova N; Rhodes T; Uuskula A
    AIDS Care; 2009 Jul; 21(7):851-7. PubMed ID: 20024741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users.
    Williams ML; McCurdy SA; Atkinson JS; Kilonzo GP; Leshabari MT; Ross MW
    AIDS Behav; 2007 Jan; 11(1):137-44. PubMed ID: 17004117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual risk behavior changes among HIV+ and HIV-female injecting drug users over 4 years.
    Dolezal C; Ehrhardt AA; Meyer-Bahlburg HF; Liu X; Exner TM; Rabkin JG; Gorman JM; Marder K; Stern Y
    Women Health; 1998; 27(4):1-17. PubMed ID: 9796081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported high-risk behavioral history of HIV positive prison inmates.
    Templer DI; Walker S
    Psychol Rep; 1995 Feb; 76(1):237-8. PubMed ID: 7770576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988-1998.
    McCoy CB; Metsch LR; Comerford M; Zhao W; Coltes AJ; Messiah SE
    AIDS Behav; 2005 Jun; 9(2):187-99. PubMed ID: 15933838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of HIV infection for noninjecting sex partners of injecting drug users in Stockholm.
    Käll K
    AIDS Educ Prev; 1994 Aug; 6(4):351-64. PubMed ID: 7986655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk behaviour associated with HIV infection among drug abusers seen at the general Hospital, Kota Bharu, Kelantan.
    Suarn S; Nor Adam M
    Med J Malaysia; 1993 Jun; 48(2):117-23. PubMed ID: 8350785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding HIV risks of chronic drug-using men who have sex with men.
    Rhodes F; Deren S; Wood MM; Shedlin MG; Carlson RG; Lambert EY; Kochems LM; Stark MJ; Falck RS; Wright-DeAgüero L; Weir B; Cottler L; Rourke KM; Trotter RT
    AIDS Care; 1999 Dec; 11(6):629-48. PubMed ID: 10716005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
    Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-risk behaviour among non-heroin using cocaine injectors and non-injectors in São Paulo, Brazil.
    Dunn J; Laranjeira RR
    AIDS Care; 2000 Aug; 12(4):471-81. PubMed ID: 11091780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.